Small-Molecule Drug Start-Ups
This article was originally published in Start Up
Companies pursuing small-molecule drugs are by far the most popular of the start-ups in biopharmaceuticals. But the biggest opportunity in the business is still up for grabs: the industrialization of medicinal chemistry.
You may also be interested in...
Small Molecule Therapeutics uses proprietary screening technologies to develop leads--in areas including anti-infectives, diabetes, immunology and hematopoiesis--which can be partnered with large pharmaceutical companies.
Atherogenics Inc. has begun clinical trials on a compound that goes to the heart of the matter by attacking the inflammation processes that can cause atherosclerosis and the build-up of plaque.
Kinetix Pharmaceuticals is a small molecule drug discovery company developing protein kinase inhibitors for four major therapuetic areas: immunosuppression/autoimmunity, asthma/allergy and inflammation.